Clinical Trials Directory

Trials / Completed

CompletedNCT02483351

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ottawa Hospital Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).

Conditions

Interventions

TypeNameDescription
OTHERLiberal Red Blood Cell Transfusion StrategyRBC Transfusion strategy with hemoglobin trigger of 100g/L
OTHERRestrictive Red Blood Cell Transfusion StrategyOptional RBC Transfusion with hemoglobin trigger of \<=80g/L

Timeline

Start date
2015-10-01
Primary completion
2018-01-01
Completion
2018-01-01
First posted
2015-06-26
Last updated
2018-04-04

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02483351. Inclusion in this directory is not an endorsement.

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome (NCT02483351) · Clinical Trials Directory